Effects of ChongMyung-Tang and ChongMyung-Tang added Hibiscus syriacus Hot water extract & Ultra-fine Powder on Microglia and Memory Deficit Model

총명탕(聰明湯)과 목근피총명탕(木槿皮聰明湯) 열수추출물, 초미세분말제형이 microglia 및 기억력 감퇴 병태모델에 미치는 영향

  • Choi, Kang-Wook (Department of Oriental Neuropsychiatry, Oriental Medicine, Daejeon University) ;
  • Lee, Sang-Ryong (Department of Oriental Neuropsychiatry, Oriental Medicine, Daejeon University) ;
  • Jung, In-Chul (Department of Oriental Neuropsychiatry, Oriental Medicine, Daejeon University)
  • 최강욱 (대전대학교 한의과대학 신경정신과학교실) ;
  • 이상룡 (대전대학교 한의과대학 신경정신과학교실) ;
  • 정인철 (대전대학교 한의과대학 신경정신과학교실)
  • Published : 2006.10.25

Abstract

This experiment was designed to investigate the effect of the CMT and MCMT hot water extract & ultra-fine powder on microglia and memory deficit model. The effects of the CMT and MCMT hot water extract on expression of IL-l${\beta}$, IL-6, TNF-${\alpha}$, NOS-II, COX-2, IL-10, TGF-${\beta}$1 mRNA and production of IL-lP, IL-6, TNF-a, NO, ROS in BV2 microglial cell line treated by lipopolysacchaide(LPS) ; serum glucose, uric acid, AChE activity of the memory deficit mice induced by scopolamine , behavior of the memory deficit mice induced by scopolamine and were investigated, respectively. The CMT and MCMT hot water extract suppressed the expression of IL-1${\beta}$, IL-6, TNF-${\alpha}$, NOS-II, COX-2 mRNA, production of IL-l${\beta}$, IL-6, TNF-${\alpha}$, NO, ROS and increased the expression of IL-10, TGF-${\beta}$l mRNA in BV2 microglial cell line treated by LPS. The MCMT hot water extract & ultra-fine powder increased glucose, decreased uric acid and AChE significantly in the serum of the memory deficit mice induced by scopolamine. The CMT and MCMT hotwater extract & ultra-fine powder groups showed significantly inhibitory effect on the scopolamine-induced impairment of memory in the experiment of Morris water maze. According to the above result, it is suggested that the CMT and MCMT hot water extract & ultra-fine powder might be usefully applied for prevention and treatment of dementia.

Keywords

References

  1. 대한한방신경정신과학회편. 한방신경정신의학, 서울, 집문당, pp 311-316, 2005
  2. 조추용, 최현자. 치매 예방과 케어, 서울, 창지사, p 49, 2002
  3. Cacquevel, M., Lebeurrier, N., Cheenne, S., Vivien, D. Cytokines in neuroinflammation and Alzheimer's disease, Current Drug Targets, 5(6):529-534, 2004 https://doi.org/10.2174/1389450043345308
  4. Kuhl, D.E., Koeppe, R.A., Minoshima, S., Snyder, S.E., Ficaro, E.P., Foster, N.L., Frey, K.A., Kilbourn, M.R. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease, Neurology, 52(4):691-699, 1999 https://doi.org/10.1212/WNL.52.4.691
  5. Mhatre, M., Floyd, R.A., Hensley, K. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets, Journal of Alzheimers disease, 6(2):147-157, 2004 https://doi.org/10.3233/JAD-2004-6206
  6. 안준익, 이용성. Beta-amyloid의 분자생물학, 한양의대학술지, 21(1):11-16, 2001
  7. 張介賓. 張氏景岳全書, 서울, 翰成社, pp 610-611, 1978
  8. 錢鏡湖. 辨證奇問全書, 台北, 甘地出版社, pp 222-225, 233-235, 1990
  9. 洪元植. 精校黃帝內經素問, 서울, 東洋醫學硏究院, pp 37, 124, 196, 229, 217-218, 229, 1985
  10. 許 浚. 東醫寶鑑, 서울, 大星文化社, pp 55-56, 1996
  11. 李尙仁 외. 漢藥臨床應用, 서울, 成輔社, pp 151-153, 308-313, 419-420, 426-428, 1990
  12. 최병만, 정인철, 이상룡. 木槿皮가 CT-105로 유도된 Alzheimer's Disease 병태 모델에 미치는 영향. 동의신경정신과학회지, 15(2):119-139, 2004
  13. 박지운. 聰明湯과 木槿皮聰明湯이 CT105와 $\beta$A로 유도된 Alzheimer's Disease病態 모델에 미치는 영향. 박사학위논문, 2004
  14. 최현정, 방나영, 송보완, 김남재, 류봉하. 한약제형 선호도에 관한 설문조사, 경희의학, 20(1):356-367, 2004
  15. Song, L.L., Du, G.J., Fan, B.Y., Zhang, D.L. Study on pharmacology of ultra-fine particles compound Rehmannia, Zhongguo Zhong Yao Za Zhi, 27(6):436-439, 2002
  16. Skehan, P., Storeng, R., Scudiero, D., Monk, A., McMahon, J., Visca, D., Warren, J.T., Kennedy, S., Boyd, M.R. New colorimetric cytotoxicity assay for anticancer drug screening, Journal of the National Cancer Institute, 82(13):1107-1112, 1990 https://doi.org/10.1093/jnci/82.13.1107
  17. Diez, M., Koistinaho, J., Kahn, K., Games, D., Hokfelt, T. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein-initial observations, Neuroscience, 100(2):259-286, 2000 https://doi.org/10.1016/S0306-4522(00)00261-X
  18. Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B., Hirsch, E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells, J Neurosci, 19(9):3440-3447, 1999 https://doi.org/10.1523/JNEUROSCI.19-09-03440.1999
  19. Tuppo, E., Arias, H. The role of inflammation in Alzheimer' disease. The International Journal of Biochemistry & Cell Biology, 37(2):289-305, 2005 https://doi.org/10.1016/j.biocel.2004.07.009
  20. Zhiming Suo, Jun Tan, Andon Placzek, Fiona Crawford, Chunhong Fang and Michael Mullan. Alzheimers -amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40, Brain Research, 807(1-2):110-117, 1998 https://doi.org/10.1016/S0006-8993(98)00780-X
  21. Peskind, E.R., Griffin, W.S., Akama, K.T., Raskind, M.A., Van Eldik. L.J. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease, Neurochemistry International, 39(5-6):409-413, 2001 https://doi.org/10.1016/S0197-0186(01)00048-1
  22. 이귀녕, 권오헌. 임상병리파일, 서울, 의학문화사, pp 169-173, 2000
  23. 대한병리학회. 병리학, 서울, 고문사, pp 87-88, 1263-1264, 1994
  24. Foster, N.L., Petersen, R.C., Gracon, S.I., Lewis, K. An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease, Dementia, 7(5):260-266, 1996
  25. Sramek, J.J., Frackiewicz, E.J., Cutler, N.R. Review of the acetylcholinesterase inhibitor galanthamine, Expert Opin Investig Drugs, 9(10):2393-2402, 2000 https://doi.org/10.1517/13543784.9.10.2393
  26. Trabace, L., Cassano, T., Steardo, L., Pietra, C., Villetti, G., Kendrick, K.M., Cuomo, V. Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease, J Pharmacol Exp Ther, 294(1):187-194, 2000
  27. Geerts H. Indicators of neuroprotection with galantamine, Brain Research Bulletin, 64(60):519-524, 2005 https://doi.org/10.1016/j.brainresbull.2004.11.002
  28. Kang, J., Park, E.J., Jou, I., Kim, J.H., Joe, E.H. Reactive oxygen species mediate A beta(25-35)-induced activation of BV-2 microglia, Neuroreport, 12(7):1449-1452, 2001 https://doi.org/10.1097/00001756-200105250-00030
  29. Chang, J.W., Young, D.A., Coleman, P.D., O'Banion, M.K. Two-dimensional gel analysis of secreted proteins induced by interleukin-1beta in rat astrocytes, Neurochem Int, 39(5-6):349-359, 2001 https://doi.org/10.1016/S0197-0186(01)00042-0
  30. surface corrugation is sufficient to improve aerosol performance of powders, Pharm Res Jan, 22(1):148-152, 2005 https://doi.org/10.1007/s11095-004-9020-4
  31. Lee, S.C., Liu, W., Dickson, D.W., Brosnan, C.F., Berman, J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. The Journal of Immunology, 150(7):2659-2667, 1993
  32. Nick, J.A., Avdi, N.J., Gerwins, P., Johnson, G.L., Worthen, G.S. Activation of p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J Immunol. 156(12):4867-4875, 1996
  33. Marcheselli, V.L., Bazan, N.G. Sustained induction of prostaglandin endoperoxide-2 by seizure in hippocampus, The Journal of biological chemistry, 271:24794-24799, 1997
  34. Pasinatti, G.M., Alsen, P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain, Neuroscience, 87(2):319-324, 1998 https://doi.org/10.1016/S0306-4522(98)00218-8
  35. Yen, G.C., Lai, H.H. et al. Nitric oxide-scavenging and antioxidant effects of Uraria crinita root, Food Chemistry, 74:471-478, 2001 https://doi.org/10.1016/S0308-8146(01)00165-0
  36. 하대유 외. 면역학, 서울, 고문사, pp 100-105, 1994
  37. Mates, J.M., Perez-Gomez, C. et al. Antioxidant enzymes and human disease, Clinical Biochemistry, 32:595, 1999 https://doi.org/10.1016/S0009-9120(99)00075-2
  38. Ebert, U., Kirch, W. Scopolamine model of dementia ; electroencephalogram findings and cognitive performance, European Journal of Clinical Investigation, 28(11):944-949, 1998 https://doi.org/10.1046/j.1365-2362.1998.00393.x